Analysis of Problems Hindering Implementation of Modern Drug Technologies: Searching for Possible Solutions


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Problems hindering the implementation of modern technologies into pharmaceutical substance manufacturing are analyzed and classified according to the degree of negative impact. Proposals for their solution were developed considering the opportunities and constraints of implementing and scaling technologies presently in the pilot stage of development. A forecast of the emergence of new technologies at both the pilot and commercial development stages was presented.

About the authors

I. A. Narkevich

St. Petersburg State Chemical-Pharmaceutical Academy

Email: nadya.kartashova@pharminnotech.com
Russian Federation, 14 Ul. Prof. Popova, St. Petersburg, 197022

Z. M. Golant

St. Petersburg State Chemical-Pharmaceutical Academy

Email: nadya.kartashova@pharminnotech.com
Russian Federation, 14 Ul. Prof. Popova, St. Petersburg, 197022

A. A. Semin

Ministry of Education and Science of the Russian Federation

Email: nadya.kartashova@pharminnotech.com
Russian Federation, Moscow, 125993

N. S. Kartashova

St. Petersburg State Chemical-Pharmaceutical Academy

Author for correspondence.
Email: nadya.kartashova@pharminnotech.com
Russian Federation, 14 Ul. Prof. Popova, St. Petersburg, 197022

A. A. Teslev

St. Petersburg State Chemical-Pharmaceutical Academy

Email: nadya.kartashova@pharminnotech.com
Russian Federation, 14 Ul. Prof. Popova, St. Petersburg, 197022


Copyright (c) 2017 Springer Science+Business Media, LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies